Over 30 years as innovative and creative transformational scientific leader with a proven track record of teamwork, timely decision making, and results orientation in meeting business objectives in organizations from $6M to $28B, by collaborating with executive leaders and KOLs to support Medical Affairs, Digital Health, R&D, Information Technology, Artificial Intelligence, Marketing, Regulatory Affairs, Quality Assurance, Clinical Operations, Translational Medicine, Pharmacovigilance, and other functional areas. Adept at KOL strategy, engagement, protocol design, reporting, and the development and delivery of scientific and educational content. 20+ years of clinical experience in academic hospitals and Phase 0-4 clinical trial settings ranging from pre-clinical research, to contributing in clinical procedures and studies, through post-treatment follow-up. An industry expert in fusing clinical trials with digital health in Cardiology, Oncology/Hematology, Immunology, Rheumatology, Dermatology, Neuroscience, Genomics, and Pediatrics.